Gene Symbol | Gene ID | Gene Info |
---|---|---|
ELF2
|
ENSG00000109381.15 | E74 like ETS transcription factor 2 |
GABPA
|
ENSG00000154727.6 | GA binding protein transcription factor subunit alpha |
ELF5
|
ENSG00000135374.5 | E74 like ETS transcription factor 5 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr4_140005737_140006129 | ELF2 | 283 | 0.888543 | -0.43 | 2.4e-01 | Click! |
chr4_140099614_140100082 | ELF2 | 1476 | 0.328608 | 0.40 | 2.8e-01 | Click! |
chr4_140002393_140002544 | ELF2 | 2876 | 0.214102 | -0.40 | 2.9e-01 | Click! |
chr4_140004414_140005367 | ELF2 | 454 | 0.785795 | 0.31 | 4.1e-01 | Click! |
chr4_140003566_140004058 | ELF2 | 1532 | 0.339346 | 0.20 | 6.1e-01 | Click! |
chr11_34523404_34523560 | ELF5 | 9864 | 0.212896 | -0.69 | 4.0e-02 | Click! |
chr11_34536133_34536284 | ELF5 | 856 | 0.664861 | -0.33 | 3.9e-01 | Click! |
chr21_27061623_27061774 | GABPA | 45183 | 0.124265 | -0.44 | 2.3e-01 | Click! |
chr21_27107460_27107661 | GABPA | 135 | 0.618126 | 0.33 | 3.8e-01 | Click! |
chr21_27107672_27107894 | GABPA | 88 | 0.616659 | 0.25 | 5.1e-01 | Click! |
chr21_27106527_27107154 | GABPA | 41 | 0.856271 | 0.03 | 9.4e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr7_106505707_106506635 | 5.90 |
PIK3CG |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
247 |
0.95 |
chr12_47609896_47610314 | 5.62 |
PCED1B |
PC-esterase domain containing 1B |
53 |
0.98 |
chr19_3179462_3180177 | 5.52 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chr17_7239932_7240900 | 5.04 |
ACAP1 |
ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 |
507 |
0.51 |
chr10_94590680_94591107 | 4.68 |
EXOC6 |
exocyst complex component 6 |
42 |
0.99 |
chr9_137288293_137289070 | 4.60 |
RXRA |
retinoid X receptor, alpha |
9747 |
0.23 |
chr19_4916483_4916936 | 4.60 |
ARRDC5 |
arrestin domain containing 5 |
13830 |
0.12 |
chrX_128914480_128914899 | 4.47 |
SASH3 |
SAM and SH3 domain containing 3 |
729 |
0.68 |
chr9_134150778_134151758 | 4.29 |
FAM78A |
family with sequence similarity 78, member A |
666 |
0.69 |
chr18_13464907_13465379 | 4.23 |
LDLRAD4 |
low density lipoprotein receptor class A domain containing 4 |
129 |
0.93 |
chr19_10346719_10347362 | 4.15 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
5078 |
0.09 |
chr11_63974616_63975431 | 3.98 |
FERMT3 |
fermitin family member 3 |
266 |
0.78 |
chr8_66863582_66864279 | 3.87 |
DNAJC5B |
DnaJ (Hsp40) homolog, subfamily C, member 5 beta |
69865 |
0.12 |
chr14_88471433_88472132 | 3.86 |
GPR65 |
G protein-coupled receptor 65 |
314 |
0.88 |
chr19_49839028_49839359 | 3.77 |
CD37 |
CD37 molecule |
472 |
0.63 |
chr3_183273606_183273960 | 3.74 |
KLHL6 |
kelch-like family member 6 |
306 |
0.89 |
chr10_11212951_11213685 | 3.65 |
RP3-323N1.2 |
|
21 |
0.98 |
chr1_6086479_6086932 | 3.59 |
KCNAB2 |
potassium voltage-gated channel, shaker-related subfamily, beta member 2 |
325 |
0.88 |
chr12_54866933_54867431 | 3.55 |
GTSF1 |
gametocyte specific factor 1 |
201 |
0.92 |
chr8_134084504_134084857 | 3.55 |
SLA |
Src-like-adaptor |
12077 |
0.24 |
chr14_101587281_101587508 | 3.54 |
ENSG00000206761 |
. |
24638 |
0.04 |
chr11_65407442_65407916 | 3.53 |
SIPA1 |
signal-induced proliferation-associated 1 |
87 |
0.92 |
chr16_29675034_29675898 | 3.51 |
QPRT |
quinolinate phosphoribosyltransferase |
866 |
0.35 |
chr2_175498105_175498391 | 3.50 |
WIPF1 |
WAS/WASL interacting protein family, member 1 |
1059 |
0.58 |
chr2_242556723_242557374 | 3.50 |
THAP4 |
THAP domain containing 4 |
132 |
0.94 |
chr12_58135257_58135844 | 3.42 |
AGAP2 |
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 |
390 |
0.63 |
chr15_80262648_80263745 | 3.42 |
BCL2A1 |
BCL2-related protein A1 |
315 |
0.89 |
chr1_111416320_111416529 | 3.40 |
CD53 |
CD53 molecule |
648 |
0.73 |
chr20_61559769_61560616 | 3.32 |
DIDO1 |
death inducer-obliterator 1 |
2337 |
0.23 |
chr1_160676943_160677601 | 3.31 |
CD48 |
CD48 molecule |
4321 |
0.18 |
chr17_66433856_66434617 | 3.24 |
WIPI1 |
WD repeat domain, phosphoinositide interacting 1 |
4524 |
0.23 |
chr16_17463239_17463649 | 3.23 |
XYLT1 |
xylosyltransferase I |
101294 |
0.09 |
chr11_3860110_3860464 | 3.19 |
RHOG |
ras homolog family member G |
1190 |
0.3 |
chr17_27220072_27220391 | 3.18 |
RP11-20B24.7 |
|
744 |
0.4 |
chr11_267625_268190 | 3.16 |
NLRP6 |
NLR family, pyrin domain containing 6 |
10458 |
0.07 |
chr16_28506110_28506360 | 3.13 |
APOBR |
apolipoprotein B receptor |
242 |
0.75 |
chr1_156124352_156124692 | 3.12 |
SEMA4A |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A |
360 |
0.78 |
chr10_73531555_73531706 | 3.11 |
C10orf54 |
chromosome 10 open reading frame 54 |
1625 |
0.38 |
chr1_161038546_161039545 | 3.07 |
ARHGAP30 |
Rho GTPase activating protein 30 |
411 |
0.65 |
chr1_26872331_26872899 | 3.04 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
272 |
0.88 |
chr19_3136242_3137376 | 3.03 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr11_67176589_67176876 | 3.03 |
TBC1D10C |
TBC1 domain family, member 10C |
5072 |
0.07 |
chr17_56408210_56408765 | 2.99 |
MIR142 |
microRNA 142 |
192 |
0.87 |
chr3_13050979_13051187 | 2.96 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
22547 |
0.24 |
chr13_31311572_31311749 | 2.94 |
ALOX5AP |
arachidonate 5-lipoxygenase-activating protein |
2015 |
0.45 |
chr17_8867884_8868296 | 2.91 |
PIK3R5 |
phosphoinositide-3-kinase, regulatory subunit 5 |
934 |
0.65 |
chr7_150180608_150181504 | 2.91 |
GIMAP7 |
GTPase, IMAP family member 7 |
30862 |
0.13 |
chr1_31229648_31230364 | 2.91 |
LAPTM5 |
lysosomal protein transmembrane 5 |
661 |
0.67 |
chr11_1874347_1875032 | 2.91 |
LSP1 |
lymphocyte-specific protein 1 |
489 |
0.65 |
chr11_121323015_121324255 | 2.90 |
RP11-730K11.1 |
|
7 |
0.95 |
chr3_193973103_193973434 | 2.89 |
CPN2 |
carboxypeptidase N, polypeptide 2 |
98779 |
0.06 |
chr20_30555715_30556040 | 2.89 |
XKR7 |
XK, Kell blood group complex subunit-related family, member 7 |
72 |
0.96 |
chr1_36042987_36043882 | 2.88 |
RP4-728D4.2 |
|
104 |
0.95 |
chr11_63974230_63974581 | 2.88 |
FERMT3 |
fermitin family member 3 |
199 |
0.84 |
chr1_161184935_161185086 | 2.87 |
FCER1G |
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
59 |
0.92 |
chr4_657800_658219 | 2.85 |
PDE6B |
phosphodiesterase 6B, cGMP-specific, rod, beta |
450 |
0.67 |
chr22_50752772_50753385 | 2.85 |
XX-C283C717.1 |
|
18 |
0.95 |
chr17_80063977_80064793 | 2.84 |
CCDC57 |
coiled-coil domain containing 57 |
4659 |
0.1 |
chr6_143140776_143141820 | 2.82 |
HIVEP2 |
human immunodeficiency virus type I enhancer binding protein 2 |
16886 |
0.26 |
chr3_13455515_13455928 | 2.82 |
NUP210 |
nucleoporin 210kDa |
6088 |
0.26 |
chr3_140985922_140986285 | 2.81 |
ACPL2 |
acid phosphatase-like 2 |
4647 |
0.28 |
chr7_150148744_150149359 | 2.80 |
GIMAP8 |
GTPase, IMAP family member 8 |
1333 |
0.41 |
chr17_72733506_72734386 | 2.79 |
RAB37 |
RAB37, member RAS oncogene family |
575 |
0.59 |
chr19_49838375_49839003 | 2.79 |
CD37 |
CD37 molecule |
5 |
0.95 |
chr19_33863308_33863524 | 2.79 |
CEBPG |
CCAAT/enhancer binding protein (C/EBP), gamma |
820 |
0.64 |
chr9_95726568_95726886 | 2.78 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
484 |
0.84 |
chr1_206732541_206732911 | 2.77 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
2233 |
0.27 |
chr10_129846734_129847253 | 2.76 |
PTPRE |
protein tyrosine phosphatase, receptor type, E |
1159 |
0.62 |
chr9_117690313_117690616 | 2.76 |
TNFSF8 |
tumor necrosis factor (ligand) superfamily, member 8 |
2233 |
0.42 |
chr1_241715191_241715459 | 2.76 |
KMO |
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
16610 |
0.2 |
chr21_43483571_43483940 | 2.75 |
UMODL1 |
uromodulin-like 1 |
687 |
0.71 |
chr7_50727890_50728167 | 2.74 |
GRB10 |
growth factor receptor-bound protein 10 |
33401 |
0.21 |
chr16_30195482_30195882 | 2.73 |
RP11-455F5.5 |
|
162 |
0.71 |
chrX_64917369_64917808 | 2.73 |
MSN |
moesin |
30051 |
0.25 |
chr1_21619720_21620176 | 2.72 |
RP5-1071N3.1 |
|
165 |
0.91 |
chr22_17700031_17700512 | 2.72 |
CECR1 |
cat eye syndrome chromosome region, candidate 1 |
5 |
0.98 |
chr1_154982220_154982994 | 2.71 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
4317 |
0.08 |
chr1_200991644_200992373 | 2.70 |
KIF21B |
kinesin family member 21B |
528 |
0.78 |
chr9_117134390_117135168 | 2.70 |
AKNA |
AT-hook transcription factor |
4465 |
0.23 |
chr22_37881738_37882044 | 2.69 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
534 |
0.71 |
chr16_88769179_88769564 | 2.68 |
RNF166 |
ring finger protein 166 |
654 |
0.43 |
chr19_48747671_48748205 | 2.67 |
CARD8 |
caspase recruitment domain family, member 8 |
3618 |
0.15 |
chr2_233925207_233925694 | 2.67 |
INPP5D |
inositol polyphosphate-5-phosphatase, 145kDa |
261 |
0.92 |
chr2_8628153_8628374 | 2.65 |
AC011747.7 |
|
187633 |
0.03 |
chr15_77289512_77289663 | 2.65 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
1672 |
0.38 |
chr12_15113710_15114247 | 2.65 |
ARHGDIB |
Rho GDP dissociation inhibitor (GDI) beta |
222 |
0.92 |
chr19_10449910_10450285 | 2.64 |
ICAM3 |
intercellular adhesion molecule 3 |
198 |
0.86 |
chr7_45067326_45068016 | 2.64 |
CCM2 |
cerebral cavernous malformation 2 |
400 |
0.81 |
chr2_61095077_61095367 | 2.63 |
REL |
v-rel avian reticuloendotheliosis viral oncogene homolog |
13434 |
0.18 |
chr12_7055489_7056183 | 2.62 |
PTPN6 |
protein tyrosine phosphatase, non-receptor type 6 |
63 |
0.9 |
chrY_2709555_2710183 | 2.61 |
RPS4Y1 |
ribosomal protein S4, Y-linked 1 |
92 |
0.98 |
chr7_150329208_150329551 | 2.61 |
GIMAP6 |
GTPase, IMAP family member 6 |
55 |
0.98 |
chr1_161037656_161037864 | 2.60 |
ARHGAP30 |
Rho GTPase activating protein 30 |
1696 |
0.16 |
chr19_1067222_1068216 | 2.60 |
HMHA1 |
histocompatibility (minor) HA-1 |
222 |
0.85 |
chr6_144665292_144666004 | 2.58 |
UTRN |
utrophin |
411 |
0.88 |
chr19_6100497_6100709 | 2.58 |
CTB-66B24.1 |
|
8730 |
0.14 |
chr11_67037576_67038089 | 2.57 |
ADRBK1 |
adrenergic, beta, receptor kinase 1 |
3880 |
0.14 |
chr11_6767215_6767876 | 2.57 |
OR2AG2 |
olfactory receptor, family 2, subfamily AG, member 2 |
22741 |
0.11 |
chr16_67679075_67679512 | 2.56 |
RLTPR |
RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing |
143 |
0.91 |
chr17_4618141_4618477 | 2.56 |
ARRB2 |
arrestin, beta 2 |
575 |
0.53 |
chr17_3866518_3867344 | 2.55 |
ATP2A3 |
ATPase, Ca++ transporting, ubiquitous |
654 |
0.71 |
chr19_15574418_15574723 | 2.55 |
RASAL3 |
RAS protein activator like 3 |
812 |
0.5 |
chr17_3819186_3819649 | 2.54 |
P2RX1 |
purinergic receptor P2X, ligand-gated ion channel, 1 |
377 |
0.84 |
chr17_2699201_2699651 | 2.52 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
306 |
0.89 |
chr15_75080868_75081404 | 2.52 |
ENSG00000264386 |
. |
38 |
0.76 |
chr17_2699734_2700214 | 2.52 |
RAP1GAP2 |
RAP1 GTPase activating protein 2 |
198 |
0.94 |
chr5_544016_544540 | 2.51 |
ENSG00000264233 |
. |
8281 |
0.14 |
chr5_14595155_14595651 | 2.51 |
FAM105A |
family with sequence similarity 105, member A |
13519 |
0.24 |
chr3_177256670_177257021 | 2.50 |
ENSG00000252028 |
. |
35505 |
0.22 |
chr19_17634183_17634515 | 2.48 |
FAM129C |
family with sequence similarity 129, member C |
239 |
0.85 |
chr12_57872273_57872424 | 2.47 |
ARHGAP9 |
Rho GTPase activating protein 9 |
45 |
0.94 |
chr17_62008816_62009028 | 2.46 |
CD79B |
CD79b molecule, immunoglobulin-associated beta |
699 |
0.54 |
chr1_198620819_198621442 | 2.46 |
PTPRC |
protein tyrosine phosphatase, receptor type, C |
12838 |
0.23 |
chr18_23713673_23714126 | 2.46 |
PSMA8 |
proteasome (prosome, macropain) subunit, alpha type, 8 |
58 |
0.98 |
chr16_81031171_81031400 | 2.46 |
CMC2 |
C-x(9)-C motif containing 2 |
979 |
0.45 |
chr7_139024892_139025088 | 2.44 |
C7orf55-LUC7L2 |
C7orf55-LUC7L2 readthrough |
115 |
0.89 |
chr17_4389769_4390006 | 2.43 |
RP13-580F15.2 |
|
239 |
0.89 |
chr11_104838069_104839428 | 2.43 |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
1345 |
0.45 |
chr13_50202653_50202904 | 2.42 |
ARL11 |
ADP-ribosylation factor-like 11 |
343 |
0.89 |
chr1_154358065_154358416 | 2.41 |
IL6R |
interleukin 6 receptor |
19429 |
0.11 |
chr9_134127628_134128133 | 2.41 |
FAM78A |
family with sequence similarity 78, member A |
18000 |
0.15 |
chr3_107846209_107846694 | 2.40 |
CD47 |
CD47 molecule |
36579 |
0.21 |
chr17_76127167_76127361 | 2.40 |
TMC8 |
transmembrane channel-like 8 |
395 |
0.51 |
chr19_6801414_6802010 | 2.39 |
VAV1 |
vav 1 guanine nucleotide exchange factor |
17583 |
0.13 |
chrX_1368129_1368460 | 2.39 |
CSF2RA |
colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage) |
19399 |
0.11 |
chr1_198633706_198634133 | 2.39 |
RP11-553K8.5 |
|
2271 |
0.37 |
chr19_36393409_36393874 | 2.38 |
HCST |
hematopoietic cell signal transducer |
201 |
0.69 |
chr22_19097272_19097922 | 2.37 |
AC004471.9 |
|
11445 |
0.11 |
chr21_44204010_44204161 | 2.36 |
AP001627.1 |
|
42217 |
0.15 |
chr1_169677361_169677776 | 2.36 |
SELL |
selectin L |
3271 |
0.25 |
chr19_17862364_17862733 | 2.36 |
FCHO1 |
FCH domain only 1 |
203 |
0.91 |
chr9_95857151_95857367 | 2.35 |
RP11-274J16.5 |
|
552 |
0.64 |
chr9_77703527_77704915 | 2.34 |
OSTF1 |
osteoclast stimulating factor 1 |
762 |
0.5 |
chr9_132650035_132650502 | 2.33 |
FNBP1 |
formin binding protein 1 |
31321 |
0.13 |
chr7_50344203_50344943 | 2.32 |
IKZF1 |
IKAROS family zinc finger 1 (Ikaros) |
195 |
0.97 |
chr9_134150453_134150757 | 2.32 |
FAM78A |
family with sequence similarity 78, member A |
1329 |
0.42 |
chr15_75160410_75160789 | 2.31 |
SCAMP2 |
secretory carrier membrane protein 2 |
4782 |
0.12 |
chr14_75989073_75989329 | 2.31 |
BATF |
basic leucine zipper transcription factor, ATF-like |
298 |
0.91 |
chr11_64509794_64509966 | 2.31 |
RASGRP2 |
RAS guanyl releasing protein 2 (calcium and DAG-regulated) |
529 |
0.68 |
chr19_48752803_48753145 | 2.30 |
CARD8 |
caspase recruitment domain family, member 8 |
49 |
0.96 |
chr22_38023673_38023836 | 2.30 |
SH3BP1 |
SH3-domain binding protein 1 |
11728 |
0.1 |
chr17_75450125_75450790 | 2.30 |
SEPT9 |
septin 9 |
295 |
0.88 |
chr14_52313408_52314007 | 2.29 |
GNG2 |
guanine nucleotide binding protein (G protein), gamma 2 |
137 |
0.97 |
chr4_1725155_1725451 | 2.29 |
TACC3 |
transforming, acidic coiled-coil containing protein 3 |
466 |
0.73 |
chr1_40847174_40847476 | 2.29 |
SMAP2 |
small ArfGAP2 |
7005 |
0.19 |
chr5_175123540_175123739 | 2.28 |
ENSG00000200648 |
. |
7262 |
0.21 |
chr17_56416562_56417088 | 2.28 |
BZRAP1-AS1 |
BZRAP1 antisense RNA 1 |
2106 |
0.19 |
chr21_46340531_46340791 | 2.28 |
ITGB2 |
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
109 |
0.73 |
chr2_136873275_136873680 | 2.28 |
CXCR4 |
chemokine (C-X-C motif) receptor 4 |
336 |
0.93 |
chr22_23528239_23528390 | 2.27 |
BCR |
breakpoint cluster region |
5762 |
0.16 |
chr7_100147933_100148164 | 2.27 |
AGFG2 |
ArfGAP with FG repeats 2 |
5242 |
0.09 |
chr1_225655628_225655947 | 2.26 |
RP11-496N12.6 |
|
2742 |
0.3 |
chr5_76146227_76146557 | 2.26 |
S100Z |
S100 calcium binding protein Z |
468 |
0.79 |
chr7_150148052_150148382 | 2.26 |
GIMAP8 |
GTPase, IMAP family member 8 |
499 |
0.78 |
chr5_10445338_10445751 | 2.26 |
ROPN1L |
rhophilin associated tail protein 1-like |
3556 |
0.18 |
chr15_40659564_40659826 | 2.26 |
RP11-64K12.4 |
|
2146 |
0.13 |
chr5_39201497_39202174 | 2.26 |
FYB |
FYN binding protein |
1294 |
0.59 |
chr7_45017629_45017804 | 2.25 |
MYO1G |
myosin IG |
981 |
0.45 |
chr19_7413904_7414409 | 2.25 |
CTB-133G6.1 |
|
308 |
0.88 |
chr10_114135452_114136486 | 2.23 |
ACSL5 |
acyl-CoA synthetase long-chain family member 5 |
12 |
0.98 |
chr16_29756930_29757303 | 2.23 |
C16orf54 |
chromosome 16 open reading frame 54 |
211 |
0.73 |
chr9_95790679_95791025 | 2.22 |
FGD3 |
FYVE, RhoGEF and PH domain containing 3 |
13510 |
0.18 |
chr12_25205029_25205380 | 2.21 |
LRMP |
lymphoid-restricted membrane protein |
1 |
0.98 |
chr1_25255138_25255978 | 2.20 |
RUNX3 |
runt-related transcription factor 3 |
54 |
0.98 |
chrX_4158791_4158942 | 2.20 |
ENSG00000264861 |
. |
342675 |
0.01 |
chr9_95821872_95822074 | 2.20 |
SUSD3 |
sushi domain containing 3 |
912 |
0.56 |
chr3_3214996_3215328 | 2.20 |
CRBN |
cereblon |
6196 |
0.2 |
chr9_92092302_92093120 | 2.19 |
SEMA4D |
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D |
2094 |
0.37 |
chrY_1730731_1731007 | 2.19 |
ENSG00000251841 |
. |
921921 |
0.0 |
chr3_172240144_172241280 | 2.18 |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
553 |
0.83 |
chr9_117145588_117145751 | 2.18 |
AKNA |
AT-hook transcription factor |
4574 |
0.23 |
chr16_3136460_3136756 | 2.17 |
ENSG00000200204 |
. |
464 |
0.56 |
chr14_22320464_22320750 | 2.17 |
ENSG00000222776 |
. |
71822 |
0.11 |
chrX_1780732_1781004 | 2.17 |
ASMT |
acetylserotonin O-methyltransferase |
25577 |
0.22 |
chr12_46661556_46662525 | 2.16 |
SLC38A1 |
solute carrier family 38, member 1 |
556 |
0.85 |
chr19_1895348_1895705 | 2.16 |
SCAMP4 |
secretory carrier membrane protein 4 |
9687 |
0.09 |
chr16_375168_375449 | 2.16 |
AXIN1 |
axin 1 |
27141 |
0.09 |
chr10_6626003_6626633 | 2.16 |
PRKCQ |
protein kinase C, theta |
4055 |
0.36 |
chr16_28506747_28507012 | 2.16 |
CLN3 |
ceroid-lipofuscinosis, neuronal 3 |
24 |
0.94 |
chr12_14923072_14924123 | 2.16 |
HIST4H4 |
histone cluster 4, H4 |
468 |
0.69 |
chrX_12991784_12992037 | 2.15 |
TMSB4X |
thymosin beta 4, X-linked |
1317 |
0.51 |
chr6_35279100_35279566 | 2.15 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
1818 |
0.34 |
chr13_46752366_46752713 | 2.15 |
LCP1 |
lymphocyte cytosolic protein 1 (L-plastin) |
3920 |
0.19 |
chrX_131614340_131615550 | 2.14 |
MBNL3 |
muscleblind-like splicing regulator 3 |
8098 |
0.3 |
chr5_130882612_130883040 | 2.14 |
RAPGEF6 |
Rap guanine nucleotide exchange factor (GEF) 6 |
14100 |
0.29 |
chr17_406395_406652 | 2.14 |
RP5-1029F21.3 |
|
112 |
0.97 |
chrY_1318204_1318445 | 2.14 |
NA |
NA |
> 106 |
NA |
chr12_104871725_104872091 | 2.14 |
CHST11 |
carbohydrate (chondroitin 4) sulfotransferase 11 |
21129 |
0.25 |
chr19_3180678_3181240 | 2.13 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
2223 |
0.2 |
chr6_41168130_41168571 | 2.13 |
TREML2 |
triggering receptor expressed on myeloid cells-like 2 |
582 |
0.65 |
chr19_38807765_38808076 | 2.13 |
YIF1B |
Yip1 interacting factor homolog B (S. cerevisiae) |
7 |
0.94 |
chr12_122096565_122097046 | 2.12 |
MORN3 |
MORN repeat containing 3 |
10755 |
0.18 |
chr13_33607800_33607951 | 2.12 |
ENSG00000221677 |
. |
7614 |
0.24 |
chr5_39218892_39219690 | 2.12 |
FYB |
FYN binding protein |
374 |
0.92 |
chr12_4383631_4384229 | 2.12 |
CCND2-AS2 |
CCND2 antisense RNA 2 |
301 |
0.78 |
chr22_50987100_50987359 | 2.11 |
KLHDC7B |
kelch domain containing 7B |
767 |
0.36 |
chr17_38074556_38074997 | 2.10 |
GSDMB |
gasdermin B |
67 |
0.96 |
chrX_118812530_118812818 | 2.10 |
SEPT6 |
septin 6 |
14118 |
0.16 |
chr22_50628950_50629632 | 2.09 |
TRABD |
TraB domain containing |
264 |
0.78 |
chr20_45318051_45318277 | 2.08 |
TP53RK |
TP53 regulating kinase |
85 |
0.97 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.8 | 11.4 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
2.6 | 7.8 | GO:0033622 | integrin activation(GO:0033622) |
2.6 | 7.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
2.0 | 6.1 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.9 | 7.8 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.9 | 5.8 | GO:0010447 | response to acidic pH(GO:0010447) |
1.7 | 1.7 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
1.6 | 4.9 | GO:0046137 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
1.6 | 4.8 | GO:0015809 | arginine transport(GO:0015809) |
1.6 | 10.9 | GO:0007172 | signal complex assembly(GO:0007172) |
1.6 | 9.3 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
1.4 | 4.3 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.3 | 1.3 | GO:0002326 | B cell lineage commitment(GO:0002326) |
1.2 | 3.7 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) detection of bacterial lipopeptide(GO:0070340) |
1.2 | 4.9 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
1.2 | 3.6 | GO:0035455 | response to interferon-alpha(GO:0035455) |
1.2 | 3.6 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.2 | 5.8 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.1 | 6.9 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
1.1 | 1.1 | GO:0002830 | positive regulation of type 2 immune response(GO:0002830) |
1.1 | 5.6 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
1.1 | 3.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
1.1 | 4.5 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.1 | 1.1 | GO:0002544 | chronic inflammatory response(GO:0002544) |
1.1 | 3.2 | GO:0051138 | NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
1.1 | 3.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.1 | 1.1 | GO:0061030 | epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
1.1 | 3.2 | GO:0090382 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
1.1 | 1.1 | GO:0006639 | neutral lipid metabolic process(GO:0006638) acylglycerol metabolic process(GO:0006639) |
1.0 | 6.3 | GO:0046643 | regulation of gamma-delta T cell activation(GO:0046643) positive regulation of gamma-delta T cell activation(GO:0046645) |
1.0 | 4.2 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 9.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
1.0 | 4.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.0 | 5.1 | GO:0031061 | negative regulation of histone methylation(GO:0031061) |
1.0 | 5.0 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
1.0 | 2.0 | GO:0032661 | interleukin-18 production(GO:0032621) regulation of interleukin-18 production(GO:0032661) |
1.0 | 4.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.0 | 5.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.0 | 1.9 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.0 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
1.0 | 2.9 | GO:0001821 | histamine secretion(GO:0001821) |
0.9 | 16.0 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.9 | 0.9 | GO:0090181 | regulation of cholesterol metabolic process(GO:0090181) |
0.9 | 12.1 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.9 | 1.8 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.9 | 2.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.9 | 2.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.9 | 7.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.9 | 7.0 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.9 | 2.6 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.9 | 2.6 | GO:0002883 | hypersensitivity(GO:0002524) regulation of hypersensitivity(GO:0002883) |
0.9 | 2.6 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.8 | 5.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.8 | 0.8 | GO:0032966 | negative regulation of collagen biosynthetic process(GO:0032966) |
0.8 | 0.8 | GO:0048541 | Peyer's patch development(GO:0048541) |
0.8 | 2.5 | GO:0032506 | cytokinetic process(GO:0032506) |
0.8 | 1.6 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 2.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.8 | 4.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.8 | 0.8 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.8 | 2.4 | GO:0045056 | transcytosis(GO:0045056) |
0.8 | 2.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.8 | 2.4 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 2.4 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.8 | 4.0 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.8 | 0.8 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.8 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 2.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.8 | 6.2 | GO:0002467 | germinal center formation(GO:0002467) |
0.8 | 1.5 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.7 | 1.5 | GO:0072393 | microtubule anchoring at microtubule organizing center(GO:0072393) |
0.7 | 2.2 | GO:0043320 | natural killer cell activation involved in immune response(GO:0002323) natural killer cell degranulation(GO:0043320) |
0.7 | 0.7 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.7 | 0.7 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.7 | 0.7 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) |
0.7 | 3.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.7 | 1.4 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
0.7 | 2.8 | GO:0003093 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.7 | 2.1 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
0.7 | 0.7 | GO:0071426 | ribonucleoprotein complex export from nucleus(GO:0071426) |
0.7 | 1.4 | GO:0060556 | regulation of vitamin metabolic process(GO:0030656) vitamin D biosynthetic process(GO:0042368) regulation of vitamin D biosynthetic process(GO:0060556) regulation of calcidiol 1-monooxygenase activity(GO:0060558) |
0.7 | 4.8 | GO:0042098 | T cell proliferation(GO:0042098) |
0.7 | 3.4 | GO:0090559 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
0.7 | 2.1 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.7 | 2.1 | GO:0032543 | mitochondrial translation(GO:0032543) |
0.7 | 0.7 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
0.7 | 1.4 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.7 | 2.0 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
0.7 | 0.7 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.7 | 2.0 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.7 | 0.7 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.7 | 5.3 | GO:0050718 | positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.7 | 1.3 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.6 | 12.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.6 | 1.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.6 | 3.2 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
0.6 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.6 | 2.6 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.6 | 0.6 | GO:0016241 | regulation of macroautophagy(GO:0016241) |
0.6 | 0.6 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.6 | 0.6 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.6 | 1.3 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 0.6 | GO:0035967 | cellular response to topologically incorrect protein(GO:0035967) |
0.6 | 9.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.6 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.6 | 1.2 | GO:2000143 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.6 | 1.9 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
0.6 | 0.6 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.6 | 1.9 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.6 | 1.2 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.6 | 0.6 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.6 | 3.0 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.6 | 3.0 | GO:0043368 | positive T cell selection(GO:0043368) |
0.6 | 2.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.6 | 7.2 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.6 | 1.8 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.6 | 0.6 | GO:0002448 | mast cell mediated immunity(GO:0002448) |
0.6 | 1.2 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.6 | 1.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
0.6 | 2.4 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.6 | 6.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.6 | 2.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.6 | 1.2 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.6 | 2.3 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.6 | 0.6 | GO:0046881 | positive regulation of gonadotropin secretion(GO:0032278) positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.6 | 3.5 | GO:0032647 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
0.6 | 2.3 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.6 | 2.3 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
0.6 | 6.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.6 | 1.7 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 2.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.6 | 15.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.6 | 2.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.6 | 1.1 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.6 | 1.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.6 | 1.7 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.6 | 1.7 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.6 | 1.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.6 | 3.9 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
0.5 | 0.5 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
0.5 | 1.1 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.5 | 1.6 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.5 | 2.2 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.1 | GO:0007041 | lysosomal transport(GO:0007041) |
0.5 | 0.5 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.5 | 0.5 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.5 | 0.5 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
0.5 | 4.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.5 | 8.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.5 | 0.5 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
0.5 | 1.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.5 | 2.6 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.5 | 0.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.5 | 1.0 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
0.5 | 5.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 0.5 | GO:0070265 | necrotic cell death(GO:0070265) |
0.5 | 2.5 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.5 | 1.5 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
0.5 | 2.5 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 2.0 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.5 | 2.0 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.5 | 3.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.5 | 0.5 | GO:0042992 | negative regulation of transcription factor import into nucleus(GO:0042992) |
0.5 | 1.0 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.5 | 2.0 | GO:0072531 | pyrimidine-containing compound transmembrane transport(GO:0072531) |
0.5 | 1.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.5 | 1.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 0.5 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.5 | 2.4 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.5 | 1.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.5 | 1.0 | GO:0042508 | tyrosine phosphorylation of Stat1 protein(GO:0042508) |
0.5 | 1.9 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
0.5 | 0.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
0.5 | 0.5 | GO:0090075 | relaxation of muscle(GO:0090075) |
0.5 | 1.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.5 | 0.5 | GO:0006828 | manganese ion transport(GO:0006828) |
0.5 | 0.9 | GO:0051461 | corticotropin secretion(GO:0051458) regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.5 | 0.5 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
0.5 | 1.9 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.5 | 1.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 0.9 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.5 | 3.3 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.5 | 4.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.5 | 0.5 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.5 | 0.5 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.5 | 3.3 | GO:0051642 | centrosome localization(GO:0051642) |
0.5 | 0.9 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.5 | 22.2 | GO:0034134 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.5 | 0.5 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.5 | 0.9 | GO:0032364 | oxygen homeostasis(GO:0032364) |
0.5 | 1.4 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.5 | 2.8 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
0.5 | 1.8 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.5 | 0.9 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
0.5 | 3.2 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.5 | 6.4 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.5 | 0.9 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.5 | 1.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.5 | 1.8 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
0.5 | 2.7 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
0.5 | 1.4 | GO:0003032 | detection of oxygen(GO:0003032) |
0.4 | 1.3 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.4 | 2.7 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.4 | 0.4 | GO:0097576 | vacuole fusion(GO:0097576) |
0.4 | 1.8 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.4 | 4.5 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.4 | 0.9 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
0.4 | 0.9 | GO:0010761 | fibroblast migration(GO:0010761) |
0.4 | 3.6 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.4 | 7.1 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.4 | 4.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.4 | 1.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.4 | 1.3 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.4 | 1.8 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
0.4 | 0.4 | GO:0031057 | negative regulation of histone modification(GO:0031057) |
0.4 | 1.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 3.1 | GO:0032613 | interleukin-10 production(GO:0032613) |
0.4 | 1.3 | GO:0045988 | negative regulation of striated muscle contraction(GO:0045988) |
0.4 | 2.2 | GO:0060023 | soft palate development(GO:0060023) |
0.4 | 1.3 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.4 | 7.7 | GO:0007032 | endosome organization(GO:0007032) |
0.4 | 5.1 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.4 | 4.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.4 | 3.4 | GO:0015671 | oxygen transport(GO:0015671) |
0.4 | 16.5 | GO:0031294 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
0.4 | 0.4 | GO:0033483 | gas homeostasis(GO:0033483) |
0.4 | 3.7 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.4 | 2.1 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.4 | 0.8 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.4 | 2.5 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.4 | 1.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 6.1 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 1.2 | GO:0002507 | tolerance induction(GO:0002507) |
0.4 | 1.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.4 | 1.6 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.4 | 1.6 | GO:0036465 | synaptic vesicle recycling(GO:0036465) synaptic vesicle endocytosis(GO:0048488) clathrin-mediated endocytosis(GO:0072583) |
0.4 | 0.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.4 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.4 | 0.4 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 0.4 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.4 | 1.2 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.4 | 0.8 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.4 | 1.2 | GO:0034626 | fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.4 | 0.8 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
0.4 | 0.4 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.4 | 1.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.4 | 0.8 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.4 | 1.2 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.4 | 0.8 | GO:0032329 | L-serine transport(GO:0015825) serine transport(GO:0032329) |
0.4 | 6.6 | GO:0016236 | macroautophagy(GO:0016236) |
0.4 | 5.8 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.4 | 0.4 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.4 | 0.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.4 | 0.8 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.4 | 1.5 | GO:0016265 | obsolete death(GO:0016265) |
0.4 | 0.8 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.4 | 10.4 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.4 | 2.7 | GO:0045116 | protein neddylation(GO:0045116) |
0.4 | 0.8 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.4 | 1.5 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.4 | 2.7 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.4 | 1.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 0.4 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.4 | 1.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.4 | 1.1 | GO:1903077 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.4 | 1.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.4 | 1.5 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.4 | 1.1 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.4 | 1.1 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.4 | 2.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.4 | 3.4 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.4 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 0.4 | GO:0010534 | regulation of activation of Janus kinase activity(GO:0010533) regulation of activation of JAK2 kinase activity(GO:0010534) positive regulation of activation of JAK2 kinase activity(GO:0010535) positive regulation of activation of Janus kinase activity(GO:0010536) |
0.4 | 2.6 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.4 | 5.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.4 | 2.2 | GO:0032986 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.4 | 1.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.4 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.4 | 0.7 | GO:0009405 | pathogenesis(GO:0009405) |
0.4 | 1.1 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.4 | 0.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.4 | 2.9 | GO:0006596 | polyamine biosynthetic process(GO:0006596) cellular biogenic amine biosynthetic process(GO:0042401) |
0.4 | 1.8 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.4 | 2.5 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.4 | 1.4 | GO:0015919 | peroxisomal membrane transport(GO:0015919) |
0.4 | 2.9 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.4 | 3.2 | GO:0033866 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.4 | 2.9 | GO:0033363 | secretory granule organization(GO:0033363) |
0.4 | 1.1 | GO:0014051 | gamma-aminobutyric acid secretion(GO:0014051) |
0.4 | 2.5 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 1.4 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.4 | 1.4 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 0.7 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 13.9 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 0.4 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 1.8 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.4 | 0.7 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
0.4 | 6.4 | GO:0045576 | mast cell activation(GO:0045576) |
0.4 | 6.3 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.3 | 0.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
0.3 | 0.3 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
0.3 | 0.7 | GO:0032048 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.3 | 0.3 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.3 | 4.2 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.3 | 5.6 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.3 | 0.7 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.3 | 1.4 | GO:0070670 | response to interleukin-4(GO:0070670) |
0.3 | 1.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.3 | 1.7 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.3 | 2.8 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.3 | 2.1 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.3 | 0.3 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
0.3 | 0.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.3 | 0.3 | GO:0002676 | regulation of chronic inflammatory response(GO:0002676) |
0.3 | 3.0 | GO:0051322 | anaphase(GO:0051322) |
0.3 | 0.3 | GO:0090312 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
0.3 | 1.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.3 | 1.7 | GO:0070897 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
0.3 | 1.7 | GO:0006342 | chromatin silencing(GO:0006342) |
0.3 | 0.3 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.3 | 2.4 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.3 | 1.0 | GO:0045007 | depurination(GO:0045007) |
0.3 | 1.0 | GO:0019532 | oxalate transport(GO:0019532) |
0.3 | 1.3 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.3 | 1.0 | GO:0050798 | activated T cell proliferation(GO:0050798) |
0.3 | 2.3 | GO:0042116 | macrophage activation(GO:0042116) |
0.3 | 2.0 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.3 | 1.3 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.3 | 1.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 1.0 | GO:0042772 | DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.3 | 15.7 | GO:0072395 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in DNA damage checkpoint(GO:0072422) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.3 | 2.0 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
0.3 | 1.0 | GO:0001832 | blastocyst growth(GO:0001832) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 2.3 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.3 | 0.3 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.3 | 0.6 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.3 | 0.3 | GO:0032392 | DNA geometric change(GO:0032392) |
0.3 | 1.9 | GO:0006265 | DNA topological change(GO:0006265) |
0.3 | 0.3 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.3 | 0.3 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) negative regulation of mRNA processing(GO:0050686) negative regulation of mRNA metabolic process(GO:1903312) |
0.3 | 1.3 | GO:0060539 | diaphragm development(GO:0060539) |
0.3 | 0.3 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
0.3 | 2.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.3 | 1.6 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.3 | 4.8 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.3 | 0.9 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
0.3 | 0.9 | GO:0090201 | negative regulation of mitochondrion organization(GO:0010823) negative regulation of release of cytochrome c from mitochondria(GO:0090201) negative regulation of apoptotic signaling pathway(GO:2001234) |
0.3 | 0.6 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.3 | 1.6 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 5.3 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 0.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.3 | 2.5 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.3 | 0.9 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.3 | 1.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.3 | 2.5 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.3 | 0.3 | GO:0071482 | cellular response to light stimulus(GO:0071482) |
0.3 | 1.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.3 | 2.8 | GO:0019079 | viral genome replication(GO:0019079) |
0.3 | 3.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.3 | 1.5 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
0.3 | 1.5 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.3 | 0.6 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.3 | 4.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.3 | 2.7 | GO:0016925 | protein sumoylation(GO:0016925) |
0.3 | 1.5 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.3 | 0.9 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 2.4 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 1.8 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.3 | 0.3 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 8.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.3 | 0.9 | GO:0033504 | floor plate development(GO:0033504) |
0.3 | 0.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.3 | 4.8 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.3 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 3.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.3 | 0.9 | GO:0097035 | phospholipid scrambling(GO:0017121) regulation of membrane lipid distribution(GO:0097035) |
0.3 | 4.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.3 | 4.1 | GO:0051693 | actin filament capping(GO:0051693) |
0.3 | 0.3 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.3 | 1.5 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.3 | 1.5 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 0.6 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.3 | 1.7 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.3 | 0.3 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
0.3 | 0.3 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.3 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 0.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.3 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.3 | 4.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.3 | 0.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.3 | 2.8 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.3 | 0.9 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 2.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.3 | 4.0 | GO:0042255 | ribosome assembly(GO:0042255) |
0.3 | 1.7 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.3 | 0.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.3 | 2.0 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.3 | 1.7 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
0.3 | 0.6 | GO:0002446 | neutrophil mediated immunity(GO:0002446) |
0.3 | 21.4 | GO:0051028 | mRNA transport(GO:0051028) |
0.3 | 0.3 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.3 | 5.9 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.3 | 1.7 | GO:0051319 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
0.3 | 0.6 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.3 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.3 | 6.7 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.3 | 4.2 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 1.7 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
0.3 | 0.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.3 | 0.3 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.3 | 1.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.3 | 0.8 | GO:0043248 | proteasome assembly(GO:0043248) |
0.3 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 2.5 | GO:0007141 | male meiosis I(GO:0007141) |
0.3 | 6.1 | GO:0046847 | filopodium assembly(GO:0046847) |
0.3 | 0.3 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) negative regulation of protein export from nucleus(GO:0046826) |
0.3 | 1.4 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.3 | 0.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.3 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.3 | 1.1 | GO:2001233 | regulation of release of cytochrome c from mitochondria(GO:0090199) regulation of apoptotic signaling pathway(GO:2001233) |
0.3 | 0.3 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.3 | 10.6 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.3 | 0.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 0.8 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.3 | 1.6 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.3 | 1.9 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.3 | 0.8 | GO:0050665 | hydrogen peroxide biosynthetic process(GO:0050665) |
0.3 | 1.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.3 | 0.8 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.3 | 7.7 | GO:0072512 | ferric iron transport(GO:0015682) transferrin transport(GO:0033572) trivalent inorganic cation transport(GO:0072512) |
0.3 | 1.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.3 | 0.3 | GO:1903051 | negative regulation of proteolysis involved in cellular protein catabolic process(GO:1903051) |
0.3 | 29.3 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.3 | 48.3 | GO:0016568 | chromatin modification(GO:0016568) |
0.3 | 0.5 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.3 | 1.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.3 | 0.3 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.3 | 1.3 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.3 | 6.8 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.3 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 0.8 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 1.0 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.3 | 0.8 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.3 | 1.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.3 | 1.6 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.3 | 2.1 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.3 | 0.5 | GO:0006595 | polyamine metabolic process(GO:0006595) |
0.3 | 0.3 | GO:0034244 | negative regulation of DNA-templated transcription, elongation(GO:0032785) negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.3 | 0.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.3 | 0.3 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.3 | 0.3 | GO:0006734 | NADH metabolic process(GO:0006734) |
0.3 | 2.3 | GO:0006400 | tRNA modification(GO:0006400) |
0.3 | 0.5 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.3 | 0.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 0.5 | GO:0071622 | regulation of granulocyte chemotaxis(GO:0071622) |
0.3 | 0.5 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.3 | 0.5 | GO:0000239 | pachytene(GO:0000239) |
0.3 | 0.3 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.3 | 0.5 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.3 | 3.3 | GO:0090174 | organelle membrane fusion(GO:0090174) |
0.3 | 2.8 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.3 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.3 | 19.1 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.3 | 2.3 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
0.3 | 2.3 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 1.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.2 | 1.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.2 | 0.2 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.2 | 0.5 | GO:0021694 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.2 | 0.5 | GO:0031579 | membrane raft organization(GO:0031579) |
0.2 | 0.2 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
0.2 | 1.0 | GO:0015793 | glycerol transport(GO:0015793) |
0.2 | 0.7 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 4.2 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 0.5 | GO:0002063 | chondrocyte development(GO:0002063) |
0.2 | 1.0 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.2 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.2 | 0.7 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.2 | 1.7 | GO:0061008 | hepaticobiliary system development(GO:0061008) |
0.2 | 91.5 | GO:0006955 | immune response(GO:0006955) |
0.2 | 0.5 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.2 | 1.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.2 | 1.9 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 2.1 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.2 | 1.9 | GO:0002682 | regulation of immune system process(GO:0002682) |
0.2 | 3.1 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.9 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.2 | 1.9 | GO:0008154 | actin polymerization or depolymerization(GO:0008154) |
0.2 | 1.4 | GO:0042797 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
0.2 | 17.1 | GO:0008380 | RNA splicing(GO:0008380) |
0.2 | 0.9 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 2.3 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.2 | 0.5 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
0.2 | 0.7 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.2 | 8.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.5 | GO:0032202 | telomere assembly(GO:0032202) |
0.2 | 0.5 | GO:0032898 | neurotrophin production(GO:0032898) |
0.2 | 0.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.2 | 0.7 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.2 | 1.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.2 | 0.5 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
0.2 | 1.1 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 0.7 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.2 | 0.9 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 2.3 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.2 | 1.6 | GO:0071242 | cellular response to ammonium ion(GO:0071242) |
0.2 | 8.9 | GO:0006413 | translational initiation(GO:0006413) |
0.2 | 0.2 | GO:0050701 | interleukin-1 secretion(GO:0050701) |
0.2 | 0.2 | GO:0044764 | multi-organism cellular process(GO:0044764) |
0.2 | 2.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.2 | 0.4 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.2 | 0.7 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
0.2 | 0.7 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.7 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.4 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.2 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.2 | 10.7 | GO:0034440 | fatty acid oxidation(GO:0019395) lipid oxidation(GO:0034440) |
0.2 | 0.4 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.2 | 0.9 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.2 | 0.2 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.2 | 3.0 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.2 | 0.9 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.2 | 1.1 | GO:0006983 | ER overload response(GO:0006983) |
0.2 | 0.9 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.2 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 5.0 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.2 | 10.6 | GO:0016071 | mRNA metabolic process(GO:0016071) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 0.2 | GO:0010915 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) |
0.2 | 0.6 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.2 | 1.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.2 | 1.1 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.2 | 1.5 | GO:0001510 | RNA methylation(GO:0001510) |
0.2 | 0.8 | GO:0006090 | pyruvate metabolic process(GO:0006090) |
0.2 | 0.4 | GO:0009173 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) pyrimidine nucleobase biosynthetic process(GO:0019856) UMP metabolic process(GO:0046049) |
0.2 | 0.2 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.2 | 3.3 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.2 | 1.0 | GO:0034311 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.2 | 2.5 | GO:0080171 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.2 | 1.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.2 | 0.4 | GO:0006473 | protein acetylation(GO:0006473) |
0.2 | 1.0 | GO:0000087 | mitotic M phase(GO:0000087) |
0.2 | 0.6 | GO:0043628 | ncRNA 3'-end processing(GO:0043628) |
0.2 | 0.6 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.2 | 0.2 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.2 | 1.0 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.2 | 0.6 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.2 | GO:0071503 | response to heparin(GO:0071503) |
0.2 | 1.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.2 | 0.6 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.2 | 0.2 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
0.2 | 0.4 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.2 | 0.2 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.2 | 0.6 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.2 | 1.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.2 | 0.4 | GO:0035246 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
0.2 | 3.6 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.2 | 0.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.2 | 12.6 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 0.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
0.2 | 4.2 | GO:0006914 | autophagy(GO:0006914) |
0.2 | 0.4 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.2 | 0.4 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
0.2 | 0.6 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.2 | 0.2 | GO:0051193 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of nucleotide catabolic process(GO:0030811) regulation of cofactor metabolic process(GO:0051193) regulation of coenzyme metabolic process(GO:0051196) regulation of ATP metabolic process(GO:1903578) |
0.2 | 1.6 | GO:0001706 | endoderm formation(GO:0001706) |
0.2 | 6.8 | GO:0019319 | hexose biosynthetic process(GO:0019319) |
0.2 | 2.7 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 1.4 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.2 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.2 | 2.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
0.2 | 0.6 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.2 | 1.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.2 | 0.4 | GO:0010107 | potassium ion import(GO:0010107) |
0.2 | 2.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.2 | 1.0 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 0.8 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.2 | 0.6 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.2 | 0.4 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.2 | 0.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.2 | 1.3 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.2 | 0.4 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.6 | GO:0009267 | cellular response to starvation(GO:0009267) |
0.2 | 0.6 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 1.1 | GO:1990778 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
0.2 | 0.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 1.9 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.2 | 0.2 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.2 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.2 | 0.6 | GO:0018195 | protein citrullination(GO:0018101) peptidyl-arginine modification(GO:0018195) |
0.2 | 1.1 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
0.2 | 0.9 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.2 | 0.6 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.2 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.2 | 0.5 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.2 | 0.7 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.2 | 0.2 | GO:0032602 | chemokine production(GO:0032602) |
0.2 | 1.1 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 0.2 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.2 | 3.6 | GO:0007051 | spindle organization(GO:0007051) |
0.2 | 0.5 | GO:0019695 | choline metabolic process(GO:0019695) |
0.2 | 0.4 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.2 | 0.2 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.2 | 0.2 | GO:0032109 | positive regulation of response to extracellular stimulus(GO:0032106) positive regulation of response to nutrient levels(GO:0032109) |
0.2 | 0.7 | GO:0007159 | leukocyte cell-cell adhesion(GO:0007159) |
0.2 | 0.5 | GO:0021591 | ventricular system development(GO:0021591) |
0.2 | 0.4 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.2 | 0.2 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
0.2 | 0.4 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 1.2 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.2 | 1.1 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.2 | 0.2 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.2 | 0.2 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
0.2 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.2 | 1.0 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.2 | 0.5 | GO:0034214 | protein hexamerization(GO:0034214) |
0.2 | 0.7 | GO:0002683 | negative regulation of immune system process(GO:0002683) |
0.2 | 3.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.0 | GO:0070570 | regulation of axon regeneration(GO:0048679) regulation of neuron projection regeneration(GO:0070570) |
0.2 | 10.2 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 1.5 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 2.5 | GO:1903321 | negative regulation of protein ubiquitination(GO:0031397) negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.2 | 2.4 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.2 | 0.2 | GO:0015865 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.2 | 5.7 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 1.3 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.2 | 0.2 | GO:2000399 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 0.3 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.2 | 1.0 | GO:0006465 | signal peptide processing(GO:0006465) |
0.2 | 0.3 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) |
0.2 | 7.1 | GO:0008033 | tRNA processing(GO:0008033) |
0.2 | 1.0 | GO:0032438 | melanosome organization(GO:0032438) |
0.2 | 0.8 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.2 | 2.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.2 | 14.2 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.2 | 0.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.2 | 0.2 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.2 | 0.2 | GO:0070842 | aggresome assembly(GO:0070842) |
0.2 | 0.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.2 | 0.2 | GO:0048664 | neuron fate determination(GO:0048664) |
0.2 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.2 | 0.5 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.2 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.2 | 0.2 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 8.4 | GO:0044033 | viral gene expression(GO:0019080) viral transcription(GO:0019083) multi-organism metabolic process(GO:0044033) |
0.2 | 0.3 | GO:0034067 | protein localization to Golgi apparatus(GO:0034067) |
0.2 | 0.3 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
0.2 | 0.3 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 2.4 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.2 | 0.6 | GO:0071715 | arachidonic acid secretion(GO:0050482) icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) arachidonate transport(GO:1903963) |
0.2 | 1.7 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.2 | 0.2 | GO:0006266 | DNA ligation(GO:0006266) |
0.2 | 8.1 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.5 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
0.2 | 3.4 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.2 | 1.6 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.2 | 0.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 1.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.2 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.2 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.2 | 0.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.2 | 0.5 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.2 | 0.6 | GO:0008628 | hormone-mediated apoptotic signaling pathway(GO:0008628) |
0.2 | 0.3 | GO:0000018 | regulation of DNA recombination(GO:0000018) |
0.2 | 0.8 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.2 | 5.6 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.2 | 0.2 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 1.2 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.1 | 1.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.7 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.1 | 0.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.3 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.1 | 5.1 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.1 | 0.3 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.1 | 0.6 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.1 | 0.1 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.1 | 0.4 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.1 | 0.4 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 2.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.6 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 1.1 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 2.1 | GO:0008064 | regulation of actin polymerization or depolymerization(GO:0008064) |
0.1 | 0.4 | GO:0000723 | telomere maintenance(GO:0000723) |
0.1 | 0.7 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.1 | 6.7 | GO:0070085 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) glycosylation(GO:0070085) |
0.1 | 0.1 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.7 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 4.2 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 0.4 | GO:0032528 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
0.1 | 0.3 | GO:0001881 | receptor recycling(GO:0001881) |
0.1 | 0.4 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.1 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
0.1 | 0.4 | GO:1902591 | vesicle coating(GO:0006901) single-organism membrane budding(GO:1902591) |
0.1 | 0.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 0.4 | GO:0002761 | regulation of myeloid leukocyte differentiation(GO:0002761) |
0.1 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.1 | 0.4 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.1 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 0.1 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.7 | GO:0015992 | proton transport(GO:0015992) |
0.1 | 0.1 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.1 | 2.6 | GO:0006302 | double-strand break repair(GO:0006302) |
0.1 | 0.8 | GO:0007031 | peroxisome organization(GO:0007031) |
0.1 | 0.8 | GO:0006862 | nucleotide transport(GO:0006862) |
0.1 | 0.1 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
0.1 | 3.0 | GO:0046649 | lymphocyte activation(GO:0046649) |
0.1 | 5.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.1 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.1 | 1.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.2 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.9 | GO:0046653 | tetrahydrofolate metabolic process(GO:0046653) |
0.1 | 0.2 | GO:0032729 | positive regulation of interferon-gamma production(GO:0032729) |
0.1 | 0.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.2 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.1 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 21.7 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.6 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.1 | 4.8 | GO:0016197 | endosomal transport(GO:0016197) |
0.1 | 8.3 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
0.1 | 0.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 0.1 | GO:0048799 | organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.6 | GO:0042743 | hydrogen peroxide metabolic process(GO:0042743) |
0.1 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 19.5 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.1 | 2.6 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.5 | GO:0046500 | S-adenosylhomocysteine metabolic process(GO:0046498) S-adenosylmethionine metabolic process(GO:0046500) |
0.1 | 0.1 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.1 | 0.7 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.1 | 0.3 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 1.0 | GO:1901071 | glucosamine-containing compound metabolic process(GO:1901071) |
0.1 | 0.3 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.1 | 0.6 | GO:0046466 | sphingolipid catabolic process(GO:0030149) membrane lipid catabolic process(GO:0046466) |
0.1 | 0.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 1.6 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.1 | 1.1 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.8 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.3 | GO:0016073 | snRNA transcription(GO:0009301) snRNA metabolic process(GO:0016073) |
0.1 | 0.3 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 2.6 | GO:0044042 | cellular glucan metabolic process(GO:0006073) glucan metabolic process(GO:0044042) |
0.1 | 0.2 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.1 | 0.1 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) receptor-mediated virion attachment to host cell(GO:0046813) |
0.1 | 0.4 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.1 | 1.1 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.3 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.1 | 0.8 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.5 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.1 | 0.2 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 1.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.1 | 12.5 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.1 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.1 | 0.9 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.1 | 0.2 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
0.1 | 3.4 | GO:0006310 | DNA recombination(GO:0006310) |
0.1 | 0.7 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.1 | 0.6 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.1 | 0.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.1 | 1.8 | GO:0061025 | membrane fusion(GO:0061025) |
0.1 | 3.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 2.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.1 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.1 | 0.4 | GO:0014888 | striated muscle adaptation(GO:0014888) |
0.1 | 0.3 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0051299 | centrosome separation(GO:0051299) |
0.1 | 2.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 0.1 | GO:0010657 | muscle cell apoptotic process(GO:0010657) regulation of muscle cell apoptotic process(GO:0010660) |
0.1 | 1.1 | GO:0007632 | visual behavior(GO:0007632) |
0.1 | 0.2 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
0.1 | 0.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.1 | 0.3 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.3 | GO:0032782 | canalicular bile acid transport(GO:0015722) bile acid secretion(GO:0032782) |
0.1 | 0.3 | GO:0017000 | antibiotic metabolic process(GO:0016999) antibiotic biosynthetic process(GO:0017000) |
0.1 | 0.3 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.1 | 0.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.3 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.2 | GO:0010906 | regulation of glucose metabolic process(GO:0010906) |
0.1 | 0.1 | GO:0070723 | response to sterol(GO:0036314) cellular response to sterol(GO:0036315) response to cholesterol(GO:0070723) cellular response to cholesterol(GO:0071397) |
0.1 | 0.2 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 2.5 | GO:0002576 | platelet degranulation(GO:0002576) |
0.1 | 0.2 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.1 | 0.2 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.4 | GO:0008105 | asymmetric protein localization(GO:0008105) |
0.1 | 0.6 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.1 | 0.1 | GO:0021984 | adenohypophysis development(GO:0021984) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.8 | GO:0044036 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.1 | 0.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 1.1 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 0.1 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.1 | 0.3 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.1 | 0.5 | GO:0006323 | DNA packaging(GO:0006323) |
0.1 | 0.1 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.1 | 0.2 | GO:0060896 | neural plate pattern specification(GO:0060896) |
0.1 | 0.2 | GO:0051905 | establishment of melanosome localization(GO:0032401) melanosome transport(GO:0032402) pigment granule transport(GO:0051904) establishment of pigment granule localization(GO:0051905) |
0.1 | 0.3 | GO:0051324 | prophase(GO:0051324) |
0.1 | 0.1 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.1 | 0.4 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.1 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
0.1 | 1.0 | GO:0006826 | iron ion transport(GO:0006826) |
0.1 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 0.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.4 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.1 | 0.2 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
0.1 | 0.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.1 | GO:0051298 | centrosome duplication(GO:0051298) |
0.1 | 0.2 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) regulation of retinal cell programmed cell death(GO:0046668) |
0.1 | 0.2 | GO:0010043 | response to zinc ion(GO:0010043) |
0.1 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.1 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.2 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
0.1 | 0.1 | GO:0010675 | regulation of cellular carbohydrate metabolic process(GO:0010675) |
0.1 | 1.0 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.1 | 0.1 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
0.1 | 0.1 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.1 | GO:0031503 | protein complex localization(GO:0031503) |
0.1 | 0.1 | GO:0030832 | regulation of actin filament length(GO:0030832) |
0.1 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.1 | 0.3 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
0.1 | 0.3 | GO:0009583 | detection of light stimulus(GO:0009583) |
0.1 | 0.4 | GO:0030317 | sperm motility(GO:0030317) |
0.1 | 0.4 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.1 | 0.3 | GO:0006541 | glutamine metabolic process(GO:0006541) |
0.1 | 0.1 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
0.1 | 0.2 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.0 | 0.8 | GO:0046034 | ATP metabolic process(GO:0046034) |
0.0 | 0.2 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.0 | GO:0060456 | positive regulation of digestive system process(GO:0060456) |
0.0 | 0.1 | GO:0007033 | vacuole organization(GO:0007033) |
0.0 | 3.9 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.0 | 0.0 | GO:0090322 | regulation of superoxide metabolic process(GO:0090322) |
0.0 | 0.0 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.0 | 3.6 | GO:0006457 | protein folding(GO:0006457) |
0.0 | 2.0 | GO:0006281 | DNA repair(GO:0006281) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.0 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0043114 | regulation of vascular permeability(GO:0043114) |
0.0 | 0.0 | GO:0060117 | auditory receptor cell development(GO:0060117) |
0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.1 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.0 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.3 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole metabolic process(GO:0033013) |
0.0 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 2.4 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0022409 | positive regulation of cell-cell adhesion(GO:0022409) |
0.0 | 0.5 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.3 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 3.0 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.0 | 0.0 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.0 | 0.1 | GO:0031023 | microtubule organizing center organization(GO:0031023) |
0.0 | 0.2 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.0 | 0.7 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.0 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0046689 | response to mercury ion(GO:0046689) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
0.0 | 0.1 | GO:0006560 | proline metabolic process(GO:0006560) |
0.0 | 0.1 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.1 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.1 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.0 | 0.1 | GO:0009109 | coenzyme catabolic process(GO:0009109) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.0 | 0.7 | GO:0006821 | chloride transport(GO:0006821) |
0.0 | 0.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.1 | GO:0007512 | adult heart development(GO:0007512) |
0.0 | 0.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.0 | 0.1 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.0 | GO:0015669 | gas transport(GO:0015669) |
0.0 | 0.4 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.0 | 0.1 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.0 | 0.0 | GO:0009309 | amine biosynthetic process(GO:0009309) |
0.0 | 0.1 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.0 | 0.0 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.0 | 0.1 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.0 | 0.2 | GO:0051329 | mitotic interphase(GO:0051329) |
0.0 | 0.0 | GO:0006304 | DNA modification(GO:0006304) |
0.0 | 0.0 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.0 | 0.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.0 | 0.0 | GO:0016458 | gene silencing(GO:0016458) |
0.0 | 0.1 | GO:0006067 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.0 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 10.5 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
1.6 | 1.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
1.6 | 4.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.5 | 5.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.3 | 4.0 | GO:0044462 | external encapsulating structure part(GO:0044462) |
1.3 | 3.8 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
1.1 | 3.3 | GO:0072487 | MSL complex(GO:0072487) |
1.0 | 3.0 | GO:0042629 | mast cell granule(GO:0042629) |
1.0 | 13.4 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.9 | 6.6 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 0.9 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.9 | 5.2 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.9 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.8 | 7.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.8 | 2.5 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.8 | 9.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.8 | 2.3 | GO:0070820 | tertiary granule(GO:0070820) |
0.8 | 6.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 5.3 | GO:0002102 | podosome(GO:0002102) |
0.7 | 7.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.7 | 5.0 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.7 | 2.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.7 | 5.5 | GO:0000145 | exocyst(GO:0000145) |
0.7 | 8.3 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.7 | 3.9 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.6 | 6.4 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.6 | 5.1 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.6 | 3.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 12.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.6 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
0.6 | 0.6 | GO:0030056 | hemidesmosome(GO:0030056) |
0.6 | 2.3 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.6 | 7.0 | GO:0032039 | integrator complex(GO:0032039) |
0.6 | 5.2 | GO:0005884 | actin filament(GO:0005884) |
0.5 | 4.4 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.5 | 2.7 | GO:0070695 | FHF complex(GO:0070695) |
0.5 | 3.2 | GO:0000791 | euchromatin(GO:0000791) |
0.5 | 0.5 | GO:0001740 | Barr body(GO:0001740) |
0.5 | 2.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.5 | 3.4 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.5 | 0.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.5 | 1.5 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.5 | 4.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.5 | 1.9 | GO:0097526 | U4/U6 x U5 tri-snRNP complex(GO:0046540) spliceosomal tri-snRNP complex(GO:0097526) |
0.5 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 0.9 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.5 | 2.8 | GO:0000125 | PCAF complex(GO:0000125) |
0.5 | 1.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.5 | 4.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 1.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 1.3 | GO:0005686 | U2 snRNP(GO:0005686) |
0.4 | 1.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.4 | 1.3 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.4 | 1.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.4 | 2.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.4 | 3.1 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.4 | 1.7 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.4 | 1.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.4 | 0.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.4 | 2.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.4 | 3.4 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 1.7 | GO:0030897 | HOPS complex(GO:0030897) |
0.4 | 1.3 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 2.1 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.4 | 2.9 | GO:0098984 | asymmetric synapse(GO:0032279) neuron to neuron synapse(GO:0098984) |
0.4 | 3.7 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.4 | 1.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 6.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.4 | 0.4 | GO:0070938 | contractile ring(GO:0070938) |
0.4 | 2.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.4 | 0.8 | GO:0005683 | U7 snRNP(GO:0005683) |
0.4 | 0.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.4 | 8.0 | GO:0005776 | autophagosome(GO:0005776) |
0.4 | 1.1 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.4 | 1.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.4 | 1.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.4 | 2.2 | GO:0034451 | centriolar satellite(GO:0034451) |
0.4 | 0.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.4 | 1.4 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.4 | 2.9 | GO:0005768 | endosome(GO:0005768) |
0.4 | 2.2 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 0.4 | GO:0070552 | BRISC complex(GO:0070552) |
0.4 | 2.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.4 | 0.7 | GO:0042641 | actomyosin(GO:0042641) |
0.4 | 19.7 | GO:0016605 | PML body(GO:0016605) |
0.4 | 1.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.3 | 1.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.3 | 2.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.3 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 1.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 1.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 3.5 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.3 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 0.7 | GO:0031932 | TORC2 complex(GO:0031932) |
0.3 | 1.4 | GO:0030891 | VCB complex(GO:0030891) |
0.3 | 1.0 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 21.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.3 | 6.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.0 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
0.3 | 1.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.3 | 3.3 | GO:0043209 | myelin sheath(GO:0043209) |
0.3 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.3 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.3 | 3.0 | GO:0030914 | STAGA complex(GO:0030914) |
0.3 | 4.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 0.3 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
0.3 | 2.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.3 | 1.3 | GO:0042825 | TAP complex(GO:0042825) |
0.3 | 32.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.3 | 17.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 1.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.3 | 5.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 3.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 4.0 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.3 | 26.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.3 | 1.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 2.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.3 | 2.1 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.3 | 5.1 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.3 | 0.9 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 6.0 | GO:0032154 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
0.3 | 4.8 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.3 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.3 | 1.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 0.6 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.3 | 1.7 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
0.3 | 1.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 2.6 | GO:0005680 | nuclear ubiquitin ligase complex(GO:0000152) anaphase-promoting complex(GO:0005680) |
0.3 | 22.9 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.3 | 0.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.3 | 0.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.3 | 1.1 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 33.7 | GO:0005769 | early endosome(GO:0005769) |
0.3 | 0.5 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.3 | 1.9 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 6.7 | GO:0098636 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.3 | 1.6 | GO:0031201 | SNARE complex(GO:0031201) |
0.3 | 1.6 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.3 | 6.6 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.3 | 5.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.3 | 0.8 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.3 | 2.1 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 1.5 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.3 | 5.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.3 | 0.8 | GO:0030904 | retromer complex(GO:0030904) |
0.3 | 5.6 | GO:0055037 | recycling endosome(GO:0055037) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 1.3 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 1.5 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.2 | 1.2 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
0.2 | 0.7 | GO:0000800 | lateral element(GO:0000800) |
0.2 | 8.2 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.7 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 4.0 | GO:0032420 | stereocilium(GO:0032420) |
0.2 | 8.9 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 3.4 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.2 | 3.6 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.2 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.2 | 2.2 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 0.7 | GO:0033150 | cytoskeletal calyx(GO:0033150) |
0.2 | 1.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 4.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.2 | 21.9 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 16.7 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.2 | 1.4 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 1.9 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.2 | 0.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 0.5 | GO:0031082 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
0.2 | 7.9 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.9 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.2 | 6.2 | GO:0030175 | filopodium(GO:0030175) |
0.2 | 0.2 | GO:0000346 | transcription export complex(GO:0000346) |
0.2 | 2.9 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.3 | GO:0005771 | multivesicular body(GO:0005771) |
0.2 | 0.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.2 | 0.9 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.2 | 8.3 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 6.5 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 2.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.2 | 24.1 | GO:0000785 | chromatin(GO:0000785) |
0.2 | 23.0 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 1.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.2 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 3.5 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 9.8 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.2 | 1.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 1.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.2 | 0.8 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.2 | 1.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.2 | 0.6 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
0.2 | 2.4 | GO:0005844 | polysome(GO:0005844) |
0.2 | 3.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.2 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 9.9 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.2 | 0.2 | GO:0030870 | Mre11 complex(GO:0030870) |
0.2 | 1.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 2.4 | GO:0005839 | proteasome core complex(GO:0005839) |
0.2 | 1.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.2 | 1.4 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.2 | 5.1 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.2 | 11.9 | GO:0010008 | endosome membrane(GO:0010008) |
0.2 | 0.6 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.2 | 0.8 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.2 | 2.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 6.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.2 | 5.0 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
0.2 | 1.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.0 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 0.4 | GO:0001652 | granular component(GO:0001652) |
0.2 | 2.8 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.2 | 0.4 | GO:0008278 | cohesin complex(GO:0008278) |
0.2 | 0.7 | GO:0005770 | late endosome(GO:0005770) |
0.2 | 1.5 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.2 | 0.6 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.2 | 3.9 | GO:0016604 | nuclear body(GO:0016604) |
0.2 | 8.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.2 | 2.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.2 | 0.4 | GO:0016585 | obsolete chromatin remodeling complex(GO:0016585) |
0.2 | 262.5 | GO:0005829 | cytosol(GO:0005829) |
0.2 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.2 | 4.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.5 | GO:0000124 | SAGA complex(GO:0000124) |
0.2 | 3.1 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.2 | 0.7 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.2 | 2.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 112.1 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 0.5 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
0.2 | 0.8 | GO:0070652 | HAUS complex(GO:0070652) |
0.2 | 1.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 1.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.2 | 5.4 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.2 | 0.8 | GO:0034464 | BBSome(GO:0034464) |
0.2 | 1.9 | GO:0000922 | spindle pole(GO:0000922) |
0.2 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.2 | 0.9 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 0.3 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.6 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.1 | 1.2 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.1 | 0.6 | GO:0032590 | dendrite membrane(GO:0032590) |
0.1 | 6.9 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 57.5 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.1 | 0.3 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 3.5 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.1 | GO:0000803 | sex chromosome(GO:0000803) XY body(GO:0001741) |
0.1 | 0.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.1 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.1 | 0.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 1.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 0.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.1 | 0.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 0.2 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 23.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 71.5 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 7.2 | GO:0005813 | centrosome(GO:0005813) |
0.1 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 1.3 | GO:0031461 | cullin-RING ubiquitin ligase complex(GO:0031461) |
0.1 | 0.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.3 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.9 | GO:0030496 | midbody(GO:0030496) |
0.1 | 0.4 | GO:1990391 | mismatch repair complex(GO:0032300) MutLalpha complex(GO:0032389) DNA repair complex(GO:1990391) |
0.1 | 5.6 | GO:0005694 | chromosome(GO:0005694) |
0.1 | 0.9 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.1 | 1.0 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 0.6 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.1 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.1 | 0.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 3.7 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 6.9 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.7 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.1 | 0.3 | GO:0036126 | outer dense fiber(GO:0001520) sperm flagellum(GO:0036126) |
0.1 | 0.2 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 0.6 | GO:0043186 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 0.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.1 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 2.5 | GO:1990904 | intracellular ribonucleoprotein complex(GO:0030529) ribonucleoprotein complex(GO:1990904) |
0.1 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.6 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 1.0 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.1 | 0.5 | GO:0030662 | coated vesicle membrane(GO:0030662) |
0.1 | 0.1 | GO:0099738 | cell cortex region(GO:0099738) |
0.1 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.1 | 0.1 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
0.1 | 0.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 1.1 | GO:1990234 | transferase complex(GO:1990234) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 104.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0060170 | ciliary membrane(GO:0060170) |
0.0 | 0.7 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 0.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0044440 | endosomal part(GO:0044440) |
0.0 | 0.0 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 59.4 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.5 | GO:0070013 | intracellular organelle lumen(GO:0070013) |
0.0 | 0.0 | GO:0005883 | neurofilament(GO:0005883) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.4 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
2.3 | 7.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.2 | 11.0 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
2.0 | 6.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
2.0 | 5.9 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.6 | 4.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.5 | 12.3 | GO:0005522 | profilin binding(GO:0005522) |
1.5 | 4.5 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.5 | 8.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.4 | 4.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.3 | 6.3 | GO:0001846 | opsonin binding(GO:0001846) |
1.2 | 2.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
1.2 | 4.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.1 | 10.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
1.1 | 3.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.1 | 3.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.1 | 18.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.0 | 1.0 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.0 | 3.0 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.0 | 3.9 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.0 | 2.9 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.9 | 2.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 2.7 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.9 | 2.6 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.9 | 2.6 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.9 | 5.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.8 | 2.5 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.8 | 2.5 | GO:0019863 | IgE binding(GO:0019863) |
0.8 | 2.5 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 4.8 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 3.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.8 | 3.1 | GO:0045569 | TRAIL binding(GO:0045569) |
0.8 | 3.8 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.8 | 2.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.7 | 7.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.7 | 7.1 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.7 | 2.1 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 4.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
0.7 | 2.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.7 | 9.6 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.7 | 6.2 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 5.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 3.3 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.7 | 2.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.6 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.6 | 2.6 | GO:0004340 | glucokinase activity(GO:0004340) |
0.6 | 1.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.6 | 6.4 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.6 | 2.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.6 | 3.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.6 | 0.6 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.6 | 2.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.6 | 1.9 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.6 | 3.7 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.6 | 1.8 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
0.6 | 4.3 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.6 | 2.4 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.6 | 1.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.6 | 1.7 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.6 | 4.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
0.6 | 5.7 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
0.6 | 2.3 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.6 | 2.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 3.4 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.6 | 2.3 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.6 | 2.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.5 | 2.2 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.5 | 1.6 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.5 | 0.5 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.5 | 4.3 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.5 | 1.6 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.5 | 2.7 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.5 | 3.7 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.5 | 1.6 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.5 | 1.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.5 | 1.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.5 | 2.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.5 | 5.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 1.6 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 1.0 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.5 | 2.0 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.5 | 0.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 1.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.5 | 9.6 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.5 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.5 | 4.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.5 | 2.5 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.5 | 1.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.5 | 1.5 | GO:0035197 | siRNA binding(GO:0035197) |
0.5 | 2.0 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.5 | 1.0 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.5 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.5 | 1.5 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.5 | 2.4 | GO:0034452 | dynactin binding(GO:0034452) |
0.5 | 14.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.5 | 5.8 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
0.5 | 2.9 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.5 | 2.4 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.5 | 2.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.5 | 7.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.5 | 0.5 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.5 | 3.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.5 | 1.9 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.5 | 3.7 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 4.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 2.8 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.5 | 18.0 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.5 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.4 | 1.3 | GO:0004476 | mannose-6-phosphate isomerase activity(GO:0004476) |
0.4 | 1.8 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.4 | 1.8 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.4 | 2.7 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 1.3 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) |
0.4 | 1.3 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 0.4 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
0.4 | 2.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.4 | 5.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.4 | 1.7 | GO:0043495 | protein anchor(GO:0043495) |
0.4 | 1.7 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.4 | 1.3 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.4 | 2.5 | GO:0005521 | lamin binding(GO:0005521) |
0.4 | 0.8 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.4 | 1.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
0.4 | 12.0 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.4 | 1.2 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.4 | 1.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.4 | 7.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.4 | 1.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.4 | 2.0 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.4 | 1.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.4 | 1.2 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 2.8 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.4 | 1.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.4 | 2.0 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.4 | 1.6 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 1.2 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.4 | 0.4 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 11.9 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 3.5 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
0.4 | 1.2 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.4 | 1.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.4 | 1.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.4 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.4 | 1.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 1.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.4 | 8.0 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.4 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.4 | 9.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 1.9 | GO:0050733 | RS domain binding(GO:0050733) |
0.4 | 0.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.4 | 1.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.4 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.4 | 1.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.4 | 2.2 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.4 | 0.7 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.4 | 2.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.4 | 1.8 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.4 | 9.5 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.4 | 2.6 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.4 | 1.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 1.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.4 | 1.4 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.4 | 1.8 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.4 | 1.4 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.4 | 6.1 | GO:0043621 | protein self-association(GO:0043621) |
0.4 | 1.8 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.4 | 7.5 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 1.1 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.4 | 20.5 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.4 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.4 | 0.7 | GO:0000828 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.4 | 2.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.4 | 1.1 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.4 | 2.5 | GO:0030332 | cyclin binding(GO:0030332) |
0.4 | 0.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.3 | 9.1 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.3 | 12.2 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.3 | 1.0 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.3 | 2.4 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.3 | 5.8 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.3 | 0.3 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 8.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 1.0 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 1.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.3 | 1.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.3 | 0.7 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.3 | 1.0 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.3 | 0.3 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.3 | 1.0 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.0 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.3 | 2.0 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.3 | 2.0 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.3 | 1.0 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 1.0 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.3 | 3.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.3 | 2.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.0 | GO:0016972 | thiol oxidase activity(GO:0016972) |
0.3 | 1.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.3 | 14.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.3 | 5.4 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.3 | 0.6 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.3 | 3.8 | GO:0060590 | ATPase regulator activity(GO:0060590) |
0.3 | 2.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.3 | 2.2 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.3 | 0.6 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.3 | 2.5 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.3 | 1.2 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.3 | 0.9 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
0.3 | 2.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.3 | 0.9 | GO:0004875 | complement receptor activity(GO:0004875) |
0.3 | 1.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.3 | 1.8 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.3 | 2.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.3 | 3.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.3 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.3 | 0.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.3 | 1.2 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.3 | 1.5 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 3.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.3 | 0.6 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.3 | 0.6 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
0.3 | 2.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.3 | 0.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.3 | 1.2 | GO:0046790 | virion binding(GO:0046790) |
0.3 | 1.5 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 0.6 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.3 | 1.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 1.5 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 4.3 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 2.6 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 0.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.3 | 0.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.3 | 3.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.3 | 1.4 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.3 | 2.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 1.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.3 | 1.7 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.3 | 0.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.3 | 1.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.3 | 8.9 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.3 | 0.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.3 | 0.5 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 0.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.3 | 23.0 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 0.5 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 6.8 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.3 | 0.8 | GO:0032450 | maltose alpha-glucosidase activity(GO:0032450) |
0.3 | 1.6 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.3 | 5.6 | GO:0002039 | p53 binding(GO:0002039) |
0.3 | 13.6 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.3 | 10.4 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.3 | 1.1 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.3 | 1.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.3 | 1.6 | GO:0070402 | NADPH binding(GO:0070402) |
0.3 | 0.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.3 | 0.8 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 3.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.3 | 2.1 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
0.3 | 0.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.3 | 4.7 | GO:0030145 | manganese ion binding(GO:0030145) |
0.3 | 1.3 | GO:0031491 | nucleosome binding(GO:0031491) |
0.3 | 0.5 | GO:0043398 | HLH domain binding(GO:0043398) |
0.3 | 4.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.3 | 1.8 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.3 | 3.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 1.0 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.3 | 2.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.3 | 1.0 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 1.0 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.3 | 0.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 2.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.3 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 2.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.3 | 0.3 | GO:0004396 | hexokinase activity(GO:0004396) |
0.3 | 0.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.3 | 2.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.3 | 1.3 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.3 | 0.5 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.3 | 4.6 | GO:0050699 | WW domain binding(GO:0050699) |
0.3 | 1.0 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.3 | 1.8 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 1.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.2 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.2 | 0.2 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 2.0 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 7.1 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.2 | 21.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 2.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.2 | 1.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 0.7 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.2 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.2 | 0.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.2 | 1.0 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.2 | 4.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
0.2 | 3.2 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 1.0 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 2.4 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.2 | 1.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.2 | 0.7 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.2 | 5.4 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.2 | 1.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.2 | 2.8 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
0.2 | 0.9 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) |
0.2 | 0.2 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 7.7 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.2 | 0.9 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.2 | 0.5 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.2 | 0.9 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.2 | 0.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.2 | 1.4 | GO:0042287 | MHC protein binding(GO:0042287) MHC class I protein binding(GO:0042288) |
0.2 | 1.2 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 5.7 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.2 | 0.7 | GO:0045545 | syndecan binding(GO:0045545) |
0.2 | 0.5 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 9.3 | GO:0042393 | histone binding(GO:0042393) |
0.2 | 0.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.2 | 3.8 | GO:0008373 | sialyltransferase activity(GO:0008373) |
0.2 | 1.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.2 | 1.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.2 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.2 | 1.3 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.2 | 2.0 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.2 | 1.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.2 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.2 | 2.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.2 | 0.6 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
0.2 | 0.6 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.2 | 0.6 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.2 | 0.6 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.2 | 1.1 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.4 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.2 | 0.8 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.4 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.2 | 1.5 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.2 | 0.2 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.2 | 8.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.2 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.2 | 0.4 | GO:0050693 | LBD domain binding(GO:0050693) |
0.2 | 1.2 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.2 | 0.2 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.2 | 0.2 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 4.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 2.2 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.2 | 0.2 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 0.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.2 | 2.0 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.2 | 0.8 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.2 | 0.4 | GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters(GO:0016796) |
0.2 | 0.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
0.2 | 0.4 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.2 | 0.2 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.2 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
0.2 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.2 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.2 | 7.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.7 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.2 | 0.8 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.8 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.6 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.2 | 2.9 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.7 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.2 | 0.4 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.2 | 58.1 | GO:0005525 | GTP binding(GO:0005525) |
0.2 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.2 | 0.6 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
0.2 | 0.9 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.2 | 0.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 41.3 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.2 | 0.6 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.2 | 1.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.4 | GO:0001848 | complement binding(GO:0001848) |
0.2 | 0.4 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
0.2 | 1.5 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.2 | 1.8 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.2 | 1.4 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.2 | 0.9 | GO:0005536 | glucose binding(GO:0005536) |
0.2 | 0.9 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 9.9 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.2 | 0.5 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
0.2 | 0.9 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.2 | 0.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 0.2 | GO:0043531 | ADP binding(GO:0043531) |
0.2 | 1.0 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
0.2 | 0.9 | GO:0015923 | mannosidase activity(GO:0015923) |
0.2 | 2.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.2 | 0.5 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.2 | 2.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 1.7 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.2 | 0.7 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 5.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 0.3 | GO:0031420 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
0.2 | 1.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.8 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.2 | 0.7 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.2 | 6.2 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.2 | 2.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.2 | 1.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 3.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.2 | 2.5 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) |
0.2 | 1.9 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 1.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.2 | 0.6 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.2 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.2 | 20.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 28.7 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
0.2 | 0.3 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.2 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 2.7 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.2 | 0.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.2 | 2.0 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 3.2 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 2.7 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 0.1 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 2.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 4.6 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.3 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.1 | 1.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 1.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 0.4 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 0.7 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 1.6 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.1 | 1.3 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.1 | 0.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 2.2 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.1 | 0.4 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 0.5 | GO:0016208 | AMP binding(GO:0016208) |
0.1 | 0.5 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
0.1 | 2.3 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 53.2 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.1 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.1 | 1.1 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 11.8 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.1 | 1.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.5 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.8 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.1 | 0.4 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.1 | 0.1 | GO:0005035 | death receptor activity(GO:0005035) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.1 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.1 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 0.1 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.1 | 0.6 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.1 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.1 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 1.1 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.1 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.5 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.6 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.1 | 0.6 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.1 | 0.5 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.1 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.4 | GO:0046030 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.1 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 1.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.1 | 0.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 3.2 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.1 | 2.0 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.3 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.1 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 2.0 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 10.6 | GO:0003682 | chromatin binding(GO:0003682) |
0.1 | 0.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.1 | 0.3 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 0.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.5 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.1 | 0.1 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.1 | 0.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.1 | 1.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 0.2 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 1.9 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.1 | 0.5 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.1 | 0.8 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.3 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 0.9 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.1 | 1.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.3 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.6 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.2 | GO:0048156 | tau protein binding(GO:0048156) |
0.1 | 2.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.3 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 1.2 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.1 | 0.6 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.4 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.1 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 1.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.3 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 0.6 | GO:0042625 | ATPase coupled ion transmembrane transporter activity(GO:0042625) |
0.1 | 0.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.5 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 0.5 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 2.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 8.5 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.4 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 0.2 | GO:0005350 | pyrimidine nucleobase transmembrane transporter activity(GO:0005350) |
0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
0.1 | 2.8 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.1 | 4.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 0.2 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.2 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 1.5 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.1 | 6.7 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
0.1 | 0.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.1 | 0.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.1 | 0.4 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.1 | 2.2 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 10.9 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.1 | 0.5 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 0.5 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.1 | 1.8 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.1 | 0.4 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.1 | 1.2 | GO:0050661 | NADP binding(GO:0050661) |
0.1 | 0.1 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.8 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 1.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.1 | 0.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 0.1 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 0.3 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.1 | 1.4 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
0.1 | 2.6 | GO:0031267 | small GTPase binding(GO:0031267) |
0.1 | 0.2 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.1 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.1 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 10.4 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.1 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.1 | 0.2 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 85.9 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.1 | 0.3 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0030354 | melanin-concentrating hormone activity(GO:0030354) |
0.1 | 0.1 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.1 | 0.4 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.0 | 0.0 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) drug transporter activity(GO:0090484) |
0.0 | 0.4 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.0 | 0.1 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.0 | 0.9 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.9 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.1 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.3 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.0 | GO:0035173 | histone kinase activity(GO:0035173) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.0 | 0.6 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.0 | 1.0 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.0 | 0.3 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.0 | GO:0033265 | choline binding(GO:0033265) |
0.0 | 0.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.0 | 2.4 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0034187 | obsolete apolipoprotein E binding(GO:0034187) |
0.0 | 0.1 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) |
0.0 | 0.1 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.0 | 0.1 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0080030 | methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.0 | 0.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.0 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
0.0 | 0.2 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.0 | 0.1 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 2.2 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.0 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
0.0 | 0.0 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.2 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.0 | 0.1 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.0 | 0.1 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 5.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.1 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.0 | 0.0 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.0 | 0.0 | GO:0044390 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.0 | 0.0 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.0 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 85.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.3 | 11.5 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
1.2 | 13.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
1.2 | 25.1 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.2 | 25.7 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.1 | 16.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.9 | 9.5 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 25.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.7 | 5.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.7 | 24.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 1.3 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.7 | 15.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.7 | 3.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.7 | 5.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 4.5 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.6 | 8.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.6 | 2.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 3.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.6 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 18.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.6 | 14.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.5 | 7.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.5 | 4.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.5 | 9.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.5 | 4.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 1.5 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 4.5 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.5 | 17.4 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.5 | 4.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 9.4 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 8.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.5 | 1.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.5 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 10.0 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.4 | 4.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 9.0 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.4 | 1.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.4 | 8.4 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.4 | 5.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 4.1 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.4 | 3.6 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 0.8 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.4 | 8.1 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 1.9 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 3.7 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.3 | 8.1 | PID FOXO PATHWAY | FoxO family signaling |
0.3 | 1.3 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.3 | 9.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.3 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.3 | 0.6 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 4.2 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.3 | 1.3 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.3 | 4.8 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 3.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.3 | 3.2 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.3 | 0.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 1.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 1.1 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 6.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 3.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 2.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.3 | 5.0 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 5.2 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.3 | 1.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.3 | 8.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 7.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.2 | 3.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 3.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.2 | 8.5 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 1.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 7.0 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 6.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.6 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 7.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.2 | 2.8 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 1.9 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.2 | 3.2 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 9.0 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 1.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 1.4 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.2 | 1.9 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 0.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 0.7 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 2.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 1.6 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.2 | 2.9 | PID ATM PATHWAY | ATM pathway |
0.2 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 4.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 4.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.2 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.2 | 0.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 4.9 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 4.8 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.2 | 1.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.2 | 3.7 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.2 | 2.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 0.6 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 1.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.7 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 0.3 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 0.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 1.4 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 0.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 4.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.5 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.0 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 3.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.1 | 0.7 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 2.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 0.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 0.7 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 0.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.1 | 1.9 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 0.1 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 0.2 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 2.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 0.1 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 1.3 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.0 | 0.1 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.0 | 0.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.2 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.8 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.5 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 1.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.1 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.3 | PID NOTCH PATHWAY | Notch signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 24.3 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.3 | 19.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.3 | 3.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
1.2 | 2.5 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.2 | 15.8 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.2 | 19.1 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.0 | 29.6 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.0 | 7.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
1.0 | 2.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.9 | 2.8 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.9 | 7.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.9 | 9.7 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 0.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.8 | 0.8 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.8 | 0.8 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.8 | 7.5 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 2.2 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.7 | 6.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.7 | 0.7 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF RAS | Genes involved in CREB phosphorylation through the activation of Ras |
0.7 | 10.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.6 | 9.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.6 | 3.1 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.6 | 4.8 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.6 | 5.3 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.6 | 31.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 9.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.6 | 15.3 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.6 | 5.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.6 | 5.5 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.5 | 8.1 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.5 | 21.0 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.5 | 1.6 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.5 | 5.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 7.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.5 | 15.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.5 | 5.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.5 | 1.5 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.5 | 2.4 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.5 | 6.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 0.5 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.4 | 0.4 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.4 | 22.7 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.4 | 5.2 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.4 | 3.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 2.6 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.4 | 2.9 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.4 | 1.7 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.4 | 7.8 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.4 | 4.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.4 | 8.1 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.4 | 14.9 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.4 | 12.9 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.4 | 5.9 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.4 | 0.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.4 | 7.3 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 0.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.4 | 3.4 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 1.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.4 | 6.8 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
0.4 | 7.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 4.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.4 | 1.5 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.4 | 1.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.4 | 6.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.4 | 6.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.4 | 0.7 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
0.4 | 1.5 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.4 | 0.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.4 | 5.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.4 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.4 | 1.1 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.3 | 1.4 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.3 | 6.2 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.3 | 5.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.3 | 0.3 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.3 | 4.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.3 | 9.1 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.3 | 22.8 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 4.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.3 | 0.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.3 | 4.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.3 | 0.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.3 | 2.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.3 | 4.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.3 | 6.9 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.3 | 8.1 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.3 | 28.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.3 | 3.0 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.3 | 1.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 2.5 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.3 | 2.8 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 4.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.3 | 1.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.3 | 3.8 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.3 | 0.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.3 | 0.8 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.3 | 2.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.3 | 10.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.3 | 1.0 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.3 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.3 | 1.8 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.3 | 14.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.3 | 3.6 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.3 | 2.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.3 | 0.5 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.3 | 0.5 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.2 | 1.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.2 | 1.0 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 3.9 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 1.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 7.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 2.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.2 | 3.2 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 4.8 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 4.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 2.6 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 4.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 6.0 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.2 | 3.9 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.2 | 0.2 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.2 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.2 | 2.0 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.2 | 11.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.2 | 2.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 1.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 0.4 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.2 | 2.2 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 29.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.2 | 6.6 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.2 | 0.4 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.2 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.2 | 2.9 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.2 | 1.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.2 | 2.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.2 | 12.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.2 | 13.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.2 | 2.9 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.2 | 1.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 2.5 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.2 | 1.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 4.3 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.2 | 3.9 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 8.8 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 1.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.2 | 2.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 5.9 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 0.2 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 2.5 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 2.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.2 | 10.6 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 1.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.2 | 4.6 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 2.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.2 | 1.9 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 0.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 2.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 2.5 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 4.0 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.2 | 1.8 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
0.2 | 0.3 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 1.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.2 | 0.2 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.2 | 6.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 6.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.2 | 1.1 | REACTOME MITOTIC G1 G1 S PHASES | Genes involved in Mitotic G1-G1/S phases |
0.2 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 1.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 7.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.9 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 0.8 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.1 | 2.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 2.0 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 2.4 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 6.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 0.4 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.1 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.1 | 4.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 0.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.1 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 3.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 2.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 0.1 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.1 | 0.7 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
0.1 | 0.8 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 5.5 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 4.1 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 3.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 1.0 | REACTOME TRANSLATION | Genes involved in Translation |
0.1 | 1.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.7 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 0.3 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 1.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 3.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 1.2 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.9 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 1.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.2 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 2.4 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.8 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 1.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.4 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 0.7 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 0.3 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.1 | 1.4 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 0.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 0.2 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
0.1 | 0.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 0.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 0.1 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 0.2 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.0 | 0.2 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 0.5 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.0 | 0.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.0 | 0.1 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.0 | 0.6 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 1.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.0 | 0.3 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.0 | 0.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.3 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
0.0 | 4.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.0 | 0.1 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |